Microbiota-Gut-Brain Axis: New Therapeutic Opportunities

Your doctor and stroke hospital should have already created a stroke protocol on this. Unless you believe in giving them a pass on incompetency. Incompetent for almost 7 years already and the board of directors is so incompetent they haven't fired everyone in the stroke department?

Have your doctor start with this;

Eating crickets can be good for your gut, according to new clinical trial 

You can get crickets at pet food stores, you get to choose between live ones and cricket crunchies so ask your doctor which is better; live or dead?

Even with all this information on gut-brain axis nothing will be done by your stroke medical professionals.  

 

• gut bacteria (25 posts to December 2012)

• Gut Microbes (5 posts to May 2015)

• gut microbiome (11 post to May 2018)

• gut microbiota (5 posts to June 2016)

• gut-brain axis (8 posts to March 2017)

• gut-brain connection (1 post to December 2017)

 

Microbiota-Gut-Brain Axis: New Therapeutic Opportunities

Caitríona Long-Smith,¹ Kenneth J. O'Riordan,¹ Gerard Clarke,^1,2 Catherine Stanton,^1,3 Timothy G. Dinan,^1,2 and John F. Cryan^1,4

¹APC Microbiome Ireland, University College Cork, Cork, Ireland; email: J.Cryan@ucc.ie
²Department of Psychiatry & Neurobehavioral Science, University College Cork, Cork, Ireland
³Teagasc Food Research Centre, Moorepark, Fermoy, Ireland
⁴Department of Anatomy and Neuroscience, University College Cork, Cork, Ireland

Download PDF Article Metrics

• Permissions
• Reprints
• Download Citation
• Citation Alerts

Abstract

The traditional fields of pharmacology and toxicology are beginning to consider the substantial impact our gut microbiota has on host physiology. The microbiota-gut-brain axis is emerging as a particular area of interest and a potential new therapeutic target for effective treatment of central nervous system disorders, in addition to being a potential cause of drug side effects. Microbiota-gut-brain axis signaling can occur via several pathways, including via the immune system, recruitment of host neurochemical signaling, direct enteric nervous system routes and the vagus nerve, and the production of bacterial metabolites. Altered gut microbial profiles have been described in several psychiatric and neurological disorders. Psychobiotics, live biotherapeutics or substances whose beneficial effects on the brain are bacterially mediated, are currently being investigated as direct and/or adjunctive therapies for psychiatric and neurodevelopmental disorders and possibly for neurodegenerative disease, and they may emerge as new therapeutic options in the clinical management of brain disorders.
Expected final online publication date for the Annual Review of Pharmacology and Toxicology, Volume 60 is January 6, 2020. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.